About
About
Caffein Pharma
We strive to understand and meet customer needs in a professional andresponsive manner. We focus on building long term partnership for mutual benefits and take responsibility for delivering on our commitment.
Caffein Pharma is an emerging pharmaceutical company committed to provide efficacious, affordable and quality medicine for healthier and happier life. Reaching patients and understanding their needs is our main concern, as we work each day with the purpose of improving access to medicine. Human life, we feel, is more important than business and that is why we promote affordability in significant way. All our efforts are our earnest attempts to reduce the disease burden in country.
At Caffein Pharma “We work hard every day to make this company the world’s most respected service brand.”
Our Values
Along with the power of science, what has remained unchanged is our fervent belief in doing business the right way, the Caffein Pharma way.
Our Governing Principles
Our philosophy, our actions and our products are testimonials to our commitment towards the patients, the healthcare ecosystem and the communities that we serve.
Who we are today
More than 53 years since DBG laid its foundation, Caffein Pharma continues to be inspired by his tenets:
- Research as a growth driver
- Technology as a critical differentiator to achieve world-class manufacturing standards
- Consistent focus on quality
- Our people as our strength
- Caring for all our stakeholders
- An accent on affordable, high-quality healthcare to address unmet patient needs
Global Manufacturing
As we continue to grow and expand, we have remained steadfast in our stated objective: to manufacture affordable and quality medicines. This is facilitated by state-of-the-art manufacturing facilities, industry-best environment, health and safety practices, and a strong emphasis on quality.
Research & Innovation
Underpinning our efforts our strong research and development credentials. It has helped us attain leadership in generics, complex generics, APIs, biosimilars and specialty. The company has till date filed 437 ANDA filings, 45 First-to-files and received 289 ANDA approvals.